Insights On Upstream Manufacturing
-
Building A Scalable Global T Cell Manufacturing Platform
6/11/2026
Achieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.
-
Why Use Pseudomonas Flourescens For Protein Expression?
6/10/2026
Choosing the right microbial host for protein expression can define downstream success or failure. Not all organisms are built for production, and the difference matters at scale.
-
Applying ncAA Incorporation To CRM197 Vaccine Carrier Protein Engineering
6/10/2026
Achieving precise, site-specific conjugation on vaccine carrier proteins requires careful structural analysis to avoid disrupting critical functional regions and immune response pathways.
-
iPSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers
6/10/2026
Controlled aggregation, oxygen management, and scalable workflows drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster optimization and confident transitions.
-
Efficient Monitoring Of Escherichia Coli Feeding Strategies
6/10/2026
Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.
-
Monitoring Of A pH Optimization Approach For CHO Cell Cultivation
6/10/2026
Cloud-based monitoring and analytics help centralize data, gain real-time insight, and improve decision-making. Enhanced visibility and collaboration enable faster optimization and consistency across development and manufacturing.
-
Chimeric Antigen Receptor Plasmid Production
6/10/2026
Parallel single-use bioreactor setups enable faster optimization, improved reproducibility, and smoother transition from development to production—supporting more efficient and consistent cell therapy workflows.
-
An Accelerated Protein Engineering Workflow Utilizing Linear DNA
6/9/2026
Cell-free expression using linear DNA enables rapid protein production without cloning. See how strategic template design improves yield, supporting faster iteration and high-throughput screening.
-
Streamlining Discovery And Development Workflows Using Engineered P. fluorescens Strains For ncAA Incorporation And Extracellular Protein Production
6/8/2026
Pseudomonas fluorescens offers a purpose-built alternative to conventional expression systems. Strain engineering platforms built around this organism can improve yields and simplify process development.
-
Accelerating Antibody Development: A Proven Path From Gene To GMP
6/5/2026
Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.